Population-based study (Matarxf3; Ageing Study), including 292 subjects (144 men and 148 women, mean age 77.0 ± 5.4). Anthropometric variables, lipid profile, glucose and blood pressure (BP) were measured; mental state (MMSE), nutritional state (MNA) and Barthel scale were performed, and were correlated to the presence of the 192 bp allele of IGF-1 gene promoter polymorphisms.
MS (ATP-III criteria) was found in 49.5 % (41.4 % in men and 57.6 % in women). The 192 bp allele of IGF-I gene promoter was distributed as: 41.9 % homozygous, 44.3 % heterozygous and 13.9 % were non-carriers of this allele. A lower prevalence of metabolic syndrome was observed in homozygous (41.9 % vs 54.9 % in heterozygous + non-carriers, p = 0.031). Mental state (MMSE), nutritional state (MNA) and Barthel scale were better in homozygous individuals compared to heterozygous and non-carriers (p = 0.015, p = 0.026 and 0.047, respectively). In men, MNA was better in homozygous with no differences in MMSE and Barthel scales. In homozygous women, BP was lower (p = 0.009) and Barthel scale was better (p = 0.05) with no differences in MMSE and MNA.
Homozygosity for the 192 bp allele of the IGF-I gene polymorphism suggests a healthier aging condition, with less prevalence of cardiometabolic disturbances, and better mental, nutritional and functional state.